1. Home
  2. SPRY vs DK Comparison

SPRY vs DK Comparison

Compare SPRY & DK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • DK
  • Stock Information
  • Founded
  • SPRY 2015
  • DK 2001
  • Country
  • SPRY United States
  • DK United States
  • Employees
  • SPRY N/A
  • DK N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • DK Integrated oil Companies
  • Sector
  • SPRY Health Care
  • DK Energy
  • Exchange
  • SPRY Nasdaq
  • DK Nasdaq
  • Market Cap
  • SPRY 1.8B
  • DK 1.6B
  • IPO Year
  • SPRY N/A
  • DK 2006
  • Fundamental
  • Price
  • SPRY $9.93
  • DK $32.12
  • Analyst Decision
  • SPRY Strong Buy
  • DK Hold
  • Analyst Count
  • SPRY 5
  • DK 12
  • Target Price
  • SPRY $31.00
  • DK $26.42
  • AVG Volume (30 Days)
  • SPRY 3.1M
  • DK 2.5M
  • Earning Date
  • SPRY 11-12-2025
  • DK 11-05-2025
  • Dividend Yield
  • SPRY N/A
  • DK 3.19%
  • EPS Growth
  • SPRY N/A
  • DK N/A
  • EPS
  • SPRY N/A
  • DK N/A
  • Revenue
  • SPRY $112,339,000.00
  • DK $10,822,600,000.00
  • Revenue This Year
  • SPRY N/A
  • DK N/A
  • Revenue Next Year
  • SPRY $188.92
  • DK N/A
  • P/E Ratio
  • SPRY N/A
  • DK N/A
  • Revenue Growth
  • SPRY 22367.80
  • DK N/A
  • 52 Week Low
  • SPRY $9.38
  • DK $11.03
  • 52 Week High
  • SPRY $18.90
  • DK $32.61
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 29.99
  • DK 65.01
  • Support Level
  • SPRY $9.38
  • DK $27.74
  • Resistance Level
  • SPRY $10.15
  • DK $32.61
  • Average True Range (ATR)
  • SPRY 0.63
  • DK 1.74
  • MACD
  • SPRY 0.03
  • DK 0.02
  • Stochastic Oscillator
  • SPRY 16.57
  • DK 91.61

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has two segments: Refining segment and Logistics segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

Share on Social Networks: